Wells Fargo’s Zymergen Inc. Common Stock ZY Stock Holding History

Wells Fargo’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-733	Closed	-$2K	–	7924
2022 Q3	$2K	Buy	733 +298	+69%	+$723	﹤0.01%	6244
2022 Q2	$0	Sell	435 -16,391	-97%	-$27.5K	﹤0.01%	7940
2022 Q1	$49K	Sell	16,826 -28,265	-63%	-$120K	﹤0.01%	5673
2021 Q4	$301K	Buy	+45,091	New	+$438K	﹤0.01%	5032
2021 Q3	–	Sell	-48	Closed	-$2K	–	7825
2021 Q2	$2K	Buy	+48	New	+$1.89K	﹤0.01%	6594

Wells Fargo's ZY Position: Q4 2022 in Review

Wells Fargo sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 733 shares — an estimated $2K sold.

Wells Fargo first reported a position in ZY in Q2 2021 and held it in 5 quarters. The position peaked at $301K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Wells Fargo reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Wells Fargo sold 733 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $2K.
Wells Fargo first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Wells Fargo's Zymergen Inc. Common Stock position peaked at $301K in Q4 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.